On August 1, 2023, a panel of the Inquiry Committee approved a Consent Agreement between BCCNM and the Registrant to address practice issues that occurred between June 2021 to February 2022 related to medication administration, patient assessment, documentation, and meeting the required competencies of their Certified Practice. Issues included providing an incorrect medication and failing to fully acknowledge and be accountable for the error; failing to adequately review and consider the impact of a Pharmanet history; and providing incomplete assessment or documentation of an assessment on various occasions.
In summary, as a result of the investigation, the Registrant has voluntarily agreed to terms equivalent to a limit and/or condition on their practice, including:
Suspension of nursing registration for one month and a reprimand for choosing not to adhere to competencies of Certified Practice and standards by practicing out of scope, administering a different antibiotic than the verbal order, and deleting the error in electronic charting.
Limits: Suspension of Certified Practice for six months pending education; will not work in charge or as sole RN for 12 months; will not supervise students or orient new staff for 12 months; will not work with more than one employer or on more than one ward for nine months; will not work in an independent position such as community care for nine months; and will work per a supervision agreement for eight months.
A structured and monitored graduated return to work, in accordance with medical recommendations.
Remedial education in documentation, medication administration, and ethics and professional responsibility.
Development of a learning plan which will be shared with their employer and with BCCNM.
A Regulatory Practice consulting program to address the foundational issues underpinning their Consent Agreement.
The Inquiry Committee is satisfied that the terms will protect the public.